Drug Supply Chain Falls as Some on Wall Street Say Shake It Off

(Bloomberg) -- Sell-side analysts at Wall Street firms are having mixed reactions to the roll-out of a proposal to limit the legal status of rebates in U.S.-run drug plans, as health-care supply ch...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.